Upgrade to SI Premium - Free Trial

bioAffinity (BIAF)

0.71 0.00 (0.00%)

Chart
Today 6M 1Y 5Y

Upcoming Events

- Earnings (8/19/26)

Latest Headlines

Form 8-K bioAffinity Technologies For: Jul 22 July 22, 2026 8:30 AM - SEC Filing bioAffinity Technologies partners with Pictor to develop asthma and COPD tests July 22, 2026 8:11 AM - StreetInsider bioAffinity Technologies and Pictor®, Inc. Partner to Develop and Commercialize bioAffinity’s Diagnostics for Asthma and COPD July 22, 2026 8:08 AM - BizWire Form 8-K bioAffinity Technologies For: Jul 07 July 7, 2026 8:54 AM - SEC Filing bioAffinity Technologies Q2 CyPath Lung sales rise over 200% year-over-year July 7, 2026 8:46 AM - StreetInsider bioAffinity Technologies’ Quarterly CyPath® Lung Sales Double to New Record as Commercial Momentum Continues July 7, 2026 8:46 AM - BizWire Form 8-K bioAffinity Technologies For: Jun 30 June 30, 2026 5:19 PM - SEC Filing Q2 Investor Summit Virtual Live Wednesday June 24 June 23, 2026 3:41 PM - StreetInsider Q2 Investor Summit Virtual Live Wednesday June 24 June 23, 2026 3:41 PM - StreetInsider bioAffinity Technologies reports preclinical siRNA findings for skin cancer June 22, 2026 8:01 AM - StreetInsider bioAffinity Technologies Reports Positive Preclinical Findings Showing Proprietary Gene Silencing Technology Is Selectively Cytotoxic to Squamous Skin Cancer Cells Without Harming Healthy Cells June 22, 2026 8:00 AM - BizWire Form 8-K bioAffinity Technologies For: Jun 16 June 18, 2026 5:07 PM - SEC Filing WallachBeth Capital Announces Closing of bioAffinity Technologies $3.2 Million Offering June 18, 2026 2:55 PM - PR NewsWire bioAffinity Technologies closes $3.2M public offering June 18, 2026 1:17 PM - StreetInsider bioAffinity Technologies Announces Closing of $3.2 Million Offering June 18, 2026 1:16 PM - BizWire Form 424B4 bioAffinity Technologies June 18, 2026 9:26 AM - SEC Filing WallachBeth Capital Announces Pricing of bioAffinity Technologies $3.2 Million Offering June 17, 2026 10:42 AM - PR NewsWire bioAffinity Technologies prices $3.2 million public offering June 17, 2026 9:25 AM - StreetInsider bioAffinity Technologies Announces Pricing of $3.2 Million Offering June 17, 2026 9:25 AM - BizWire Form EFFECT bioAffinity Technologies June 17, 2026 6:04 AM - SEC Filing Form S-1/A bioAffinity Technologies June 16, 2026 4:00 PM - SEC Filing Form 8-K bioAffinity Technologies For: Jun 16 June 16, 2026 8:30 AM - SEC Filing BIOAFFINITY, Philips and 4DMEDICAL to host veteran lung health webinar June 16, 2026 8:06 AM - StreetInsider bioAffinity Technologies Announces Program to Advance Veteran Lung Health: Philips, bioAffinity Technologies and 4DMedical Highlight New Approaches to Lung Health Screening for U.S. Veterans June 16, 2026 8:06 AM - BizWire Form S-1 bioAffinity Technologies June 12, 2026 5:10 PM - SEC Filing Form 8-K bioAffinity Technologies For: Jun 02 June 2, 2026 8:30 AM - SEC Filing Multidisciplinary Physician Panel to Share Real-World Benefits of bioAffinity Technologies’ Noninvasive CyPath Lung Cancer Test in Upcoming Society for Advanced Bronchoscopy Webinar June 2, 2026 8:00 AM - BizWire Form 8-K bioAffinity Technologies For: May 27 May 27, 2026 8:30 AM - SEC Filing bioAffinity Technologies receives Mexico patent allowance for lung cancer test May 27, 2026 8:01 AM - StreetInsider bioAffinity Technologies Announces Notification of Mexico Patent Allowance Covering Novel Lung Cancer Detection Methods Using CyPath® Lung Technology May 27, 2026 8:00 AM - BizWire Form S-8 bioAffinity Technologies May 20, 2026 4:26 PM - SEC Filing Form 424B3 bioAffinity Technologies May 14, 2026 4:06 PM - SEC Filing Form EFFECT bioAffinity Technologies May 13, 2026 6:07 AM - SEC Filing Form 8-K bioAffinity Technologies For: May 12 May 12, 2026 9:20 AM - SEC Filing bioAffinity Technologies reports 300% rise in lung test sales May 12, 2026 9:15 AM - StreetInsider bioAffinity Technologies Reports Record Monthly CyPath® Lung Unit Sales and Significant Year-Over-Year Growth in April 2026 May 12, 2026 9:15 AM - BizWire Form 10-Q bioAffinity Technologies For: Mar 31 May 11, 2026 6:02 AM - SEC Filing bioAffinity (BIAF) Misses Q1 EPS by 81c May 8, 2026 9:32 AM - StreetInsider Form 8-K bioAffinity Technologies For: May 08 May 8, 2026 8:31 AM - SEC Filing bioAffinity Technologies Reports First Quarter 2026 Results and Expanding Adoption and Clinical Usage of CyPath® Lung May 8, 2026 8:30 AM - BizWire Form S-1 bioAffinity Technologies April 30, 2026 5:08 PM - SEC Filing Form 8-K bioAffinity Technologies For: Apr 30 April 30, 2026 4:32 PM - SEC Filing bioAffinity Technologies Launches New Study To Expand Use of CyPath® Lung Technology for Asthma and COPD Diagnosis and Treatment April 28, 2026 9:16 AM - BizWire Full Article List